Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Marine Microbe Could Help Clear Chronic Sinusitis

By BiotechDaily International staff writers
Posted on 06 Mar 2013
Image: The bacterium Bacillus licheniformis (Photo courtesy of Newcastle University).
Image: The bacterium Bacillus licheniformis (Photo courtesy of Newcastle University).
An enzyme isolated from the marine bacterium Bacillus licheniformis incorporated into a nasal spray could help relieve chronic rhinosinusitis (CRS), according to a new study.

Researchers at Newcastle University (United Kingdom) collected mucous and sinus biopsy samples from 20 different patients, isolating between two and six different species of bacteria from each individual. In the laboratory, 24 different strains were investigated, all of which produced a slimy protective biofilm made up of a mass of bacteria held in a web of extracellular DNA that bind the bacteria to each other. This clumping protects the bacteria from attack by antibiotics, making it very difficult to clear them from the sinuses.

Based on previous studies of the marine bacterium—investigated as a tool for cleaning ship hulls—the researchers found that when the bacteria want to move, they release a deoxyribonuclease enzyme, called NucB, which breaks down the external DNA, resulting in dissolution of the biofilm and release of the bacteria. When NucB was purified and added to 14 other biofilms, the researchers succeeded in quickly dissolving the slimy biofilm, exposing the bacteria and leaving them vulnerable. The study was published on February 19, 2013, in PLOS One.

“In effect, the enzyme breaks down the extracellular DNA, which is acting like a glue to hold the cells to the surface of the sinuses. In the lab, NucB cleared over half of the organisms we tested,” said corresponding author Nicholas Jakubovics, PhD, of Newcastle University.

“For many people, symptoms include a blocked nose, nasal discharge, or congestion, recurrent headaches, loss of the sense of smell and facial pain,” added Mr. Mohamed Reda Elbadawey, a consultant of Otolaryngology Head and Neck Surgery at the Newcastle Hospitals NHS Foundation Trust (United Kingdom). “While steroid nasal sprays and antibiotics can help some people, for the patients I see, they have not been effective and these patients have to undergo the stress of surgery. If we can develop an alternative we could benefit thousands of patients a year.”

Persistent colonization of microbial biofilms is a major factor in the pathogenesis of CRS, with obstructive mucin biofilms detected on the mucosa in the paranasal sinuses, with or without polyps, and in the absence of other symptoms that would indicate fungal rhinosinusitis. The removal of this mucin, which is extremely tenacious, is the cornerstone of surgical treatment of CRS.

Related Links:

Newcastle University
Newcastle Hospitals NHS Foundation Trust



RANDOX LABORATORIES
SLAS - Society for Laboratory Automation and Screening
BIOSIGMA S.R.L.
comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: A 3-dimensional picture reveals how the antibodies in the experimental drug Zmapp bind to Ebola virus (Photo courtesy of the Scripps Research Institute).

Electron Microscope Imaging Shows How Experimental Anti-Ebola Drug Works

Electron microscope imaging has revealed how the experimental drug ZMapp binds to the Ebolavirus and provides insights into how the drug prevents growth of the pathogen. ZMapp, which was developed by... Read more

Drug Discovery

view channel

Omega 3 Found to Improve Behavior in Children with ADHD

Supplements of the fatty acids omega 3 and 6 can help children and adolescents who have a specific kind of have attention deficit hyperactivity disorder (ADHD). Moreover, these findings indicate that a customized cognitive training program can improve problem behavior in children with ADHD. Statistics show that 3%–6%... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Lab Technologies

view channel

e-Incubator Technology Provides Real-Time Imaging of Bioengineered Tissues in a Controlled Unit

A new e-incubator, an innovative miniature incubator that is compatible with magnetic resonance imaging (MRI), enables scientists to grow tissue-engineered constructs under a controlled setting and to study their growth and development in real time without risk of contamination or damage. Offering the potential to test... Read more

Business

view channel

Two Industry Partnerships Initiated to Fuel Neuroscience Research

Faster, more complex neural research is now attainable by combining technology from two research companies. Blackrock Microsystems, LLC (Salt Lake City, UT, USA), a developer of neuroscience research equipment, announced partnerships with two neuroscience research firms—PhenoSys, GmbH (Berlin, Germany) and NAN Instruments, Ltd.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.